Sonrotoclax overcomes BCL2 G101V mutation-induced venetoclax resistance in preclinical models of hematologic malignancy
Sonrotoclax 可克服血液系统恶性肿瘤临床前模型中 BCL2 G101V 突变引起的维奈克拉耐药性
期刊:Blood
影响因子:21
doi:10.1182/blood.2023019706
Jiuyang Liu, Shuran Li, Qin Wang, Yingcai Feng, Haimei Xing, Xuefei Yang, Ying Guo, Yunhang Guo, Hanzi Sun, Xiaoxin Liu, Shasha Yang, Zhu Mei, Yutong Zhu, Zhenzhen Cheng, Shuaishuai Chen, Min Xu, Wenjing Zhang, Nanyan Wan, Jia Wang, Yanwen Ma, Shuo Zhang, Xudong Luan, Aiying Xu, Lin Li, Haitao Wang,